AdvisorShares Pure Cannabis ETF (NY:YOLO)

2.740 -0.058 (-2.09%)

Delayed Quote Updated: 10:52 AM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Pure Cannabis ETF

< Previous 1 2 3 4 5 Next >

2 of the Best Buys Among Cannabis Stocks Right Now ↗

October 11, 2022

These companies' shares are down, but their revenue is on the upswing, both sequentially and year over year.

Via The Motley Fool

3 Top Marijuana Stocks to Buy for the Long Haul ↗

October 07, 2022

The three have the financial strength to benefit from increased cannabis sales and cannabis therapies.

Via The Motley Fool

Top And Flop ETFs Of Nine Months Of 2022 ↗

September 30, 2022

Here are three ETFs each from the best and worst-performing zones of the nine months of 2022.

Via Talk Markets

AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX ↗

August 24, 2022

AdvisorShares revealed that the AdvisorShares MSOS 2x Daily ETF (ARCA:MSOX) will begin trading on August 24th.

Via Benzinga

Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama ↗

August 15, 2022

By Franca Quarneti via El Planteo.

Via Benzinga

A Bear Market Setting Up A Huge Bull Market ↗

February 06, 2022

In this video, I discuss how a bear market may be setting up a huge bull market in the near future. Let's take a look.

Via Talk Markets

You Only Lose Once ↗

January 09, 2022

You may not believe this – and I didn’t know it was true until just a few minutes ago – but there is actually an ETF with the symbol YOLO. As you might guess, this seems to be targeted at those with a...

Via Talk Markets

Volatility Of Cannabis Stocks: Schumer's Bill Was A 'Hail Mary', But Industry Has Other Catalysts – Experts Explain ↗

August 01, 2022

This was a very challenging year for pot stocks. Year-to-date, AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) dropped 54.01%, AdvisorShares Pure Cannabis ETF (ARCA:YOLO) declined 57.46%, compared...

Via Benzinga

Marijuana ETFs: Which One Is Right For You? ↗

July 28, 2022

Determining which marijuana ETF to buy like comparing apples to oranges to peaches to pears. They're all fruits and grow on trees but they all taste differently and so it is with marijuana ETFs.

Via Talk Markets

Panama Will Be A Pharmaceutical Hub For The Cannabis Industry - And This Event Will Be Fundamental To Its Development ↗

July 25, 2022

On September 1 and 2, 2022, LATAM CANN.BIZ will be held in Panama. More than 40 experts, executives, medical professionals and political actors meet to discover the opportunities for economic...

Via Benzinga

High Tide Faces 'Tough Market Climate' For Retail, Analyst Lowers Price Target On Cannabis Stock ↗

July 25, 2022

High Tide (NASDAQ: HITI) recently closed a $10 million deal equity financing deal.

Via Benzinga

Are Any Marijuana Stocks On U.S. Exchanges Buys Amid More Layoffs? ↗

July 06, 2022

Canadian marijuana stocks are still struggling to find momentum, with U.S. legislation in flux. So are any Canadian marijuana stocks buys now?

Via Investor's Business Daily

Tilray Vs. Canopy Growth: Which Cannabis Stock Deserves Premium Valuation? Analyst Opines ↗

April 28, 2022

Canopy Growth Corp. (NASDAQ: CGC) recently confirmed that it is undertaking a series of initiatives, including layoffs, to reduce costs and drive efficiency in order to accelerate its path to...

Via Benzinga

Oil and Wheat? The Big Money Is Actually in Gold (and Cannabis!) ↗

April 12, 2022

Did you miss out on your chance to invest in oil and wheat? These second-order stocks still give you a chance to get in on the trends.

Via InvestorPlace

Tilray’ Downtrend Should Soon Come to an End ↗

February 17, 2022

TLRY stock is well positioned to benefit from the loosening of cannabis regulations, and had set itself up for long-term success.

Via InvestorPlace

Cannabis Stocks Chart: Renewed Legalization Hopes Widen The Valuation Gap ↗

February 16, 2022

The graph shows the Enterprise Value to Next Twelve Months (NTM) EBITDA ratios for two groups of cannabis companies: ...

Via Benzinga

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More ↗

February 11, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Via Benzinga

Chart: Is Cannabis Debt Priced Accurately? This Unique Credit Tracker Has The Answer ↗

February 08, 2022

Viridian Capital’s proprietary Cannabis Credit Tracker utilizes 11 financial and market variables to determine a cannabis company’s credit score, including Liquidity, Leverage, Profitability, and Size....

Via Benzinga

The Week In Cannabis: House Approves Banking Bill, Stocks Surge, Mississippi Legalizes Medical, M&A, Hexo's Troubles And More ↗

February 04, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of January 31st, 2022. Contents

Via Benzinga

The Week In Cannabis: Amazon Supports Legalization, NY Expands Its Medical Program, Stocks Underperform And More ↗

January 28, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of January 24, 2022. Contents

Via Benzinga

The Week In Cannabis: Senate Candidate Sparks Up, Silver Spike's IPO, New York, Mississippi, Pot For Plasma And More ↗

January 21, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of January 17, 2022.

Via Benzinga

[EXCLUSIVE] Whitney Tilson Bullish On US Cannabis Stocks: 'The Sentiment Is Changing' ↗

January 18, 2022

Investment expert and former hedge fund manager Whitney Tilson, current president and CEO of Empire Financial Research,

Via Benzinga

The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More ↗

January 14, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of January 10, 2022.

Via Benzinga

The Canadian Cannabis Market Continues To Grow While The Capital Markets Continue To Underperform ↗

January 07, 2022

Although COVID has been a headwind for growth, the Canadian cannabis sector benefited from an increase in the number of retail outlets as well as falling flower prices.

Via Talk Markets

This Industry Grew During Covid, Against All Odds: Here's Why You Should Consider Investing ↗

December 30, 2021

“Crisis can be… a catalyst or can speed up changes that are on the way — it almost can serve as an accelerant,” said ...

Via Benzinga

10 Weed Strains That Will Help Suppress Your Appetite: Avoid The Marijuana Munchies ↗

December 28, 2021

By Maria Loreto. This article was originally posted on

Via Benzinga

What Drove Cannabis Legalization? An Analysis Of 3M Reddit Posts Reveals Key Arguments That Helped Make Marijuana Legal ↗

December 27, 2021

What has influenced the recent marijuana legalization movement? Probably many factors like more research on...

Via Benzinga

BofA Lowers Price Target & Rating On Canopy Despite Its Strong Cash Position And U.S. Entry Plan...Why? ↗

December 22, 2021

Year-to-date, Canopy Growth (NASDAQ:CGC) stock lost 68.45%,...

Via Benzinga

The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More ↗

December 17, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021.

Via Benzinga

What Makes Hexo An Acquisition Target Despite Its Cash Burn And Dilution Risk? ↗

December 15, 2021

Canadian cannabis company HEXO (NASDAQ:HEXO)&nbs...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.